VITILIGO ASSOCIATED WITH BCG-METHANOL EXTRACTION RESIDUE IN MALIGNANT-MELANOMA - REPORT OF A CASE

被引：8

作者：

COHEN, Y

HAIM, S

BARTAL, A

ROBINSON, E

机构：

[1] RAMBAM MED CTR, DEPT DERMATOL, HAIFA, ISRAEL

[2] RAMBAM MED CTR, INST ONCOL, HAIFA, ISRAEL

[3] ABA KHOUSHY SCH MED, HAIFA, ISRAEL

来源：

DERMATOLOGICA | 1979年 / 158卷 / 01期

关键词：

Adjuvant immunotherapy; Malignant melanoma; Treatment with MER/ BCG; Vitiliginous reaction;

D O I：

10.1159/000250737

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

A pronounced vitiliginous reaction developed at the sites of MER/BCG injections given as an adjuvant immunotherapy to a patient with malignant melanoma. To our knowledge, this is the third report on patients exhibiting vitiligo apparently induced by immunotherapy and the first in association with MER. This association may be a sign for an antimelanocytic effect and may offer a further confirmation for the autoimmune nature of vitiligo. © 1979 S. Karger AG, Basel.

引用

页码：8 / 12

页数：5

共 26 条

[1] BCG AND CANCER .2.
BAST, RC
ZBAR, B
BORSOS, T
RAPP, HJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (26) : 1458 - 1469
[2] BROSTOFF J, 1969, LANCET, V2, P177
[3] BURDICK KH, 1964, CANCER, V17, P708, DOI 10.1002/1097-0142(196406)17:6<708::AID-CNCR2820170604>3.0.CO
[4] 2-3
[5] COPEMAN PWM, 1973, BRIT J DERMATOL, V88, P127
[6] VITILIGO THYROID DISEASE AND AUTOIMMUNITY
CUNLIFFE, WJ
HALL, R
NEWELL, DJ
STEVENSO.CJ
[J]. BRITISH JOURNAL OF DERMATOLOGY, 1968, 80 (03) : 135 - &
[7] DAWBER RPR, 1968, DIABETES, V17, P388
[8] DONALDSON RC, 1974, SURGERY, V76, P771
[9] FITZPATRICK TB, 1971, DERMATOLOGY GENERAL, P1615
[10] GRANT RM, 1974, LANCET, V2, P1096

← 1 2 3 →